share_log

Omeros Says Narsoplimab Arm of COVID-19 Treatment Trial in Critically Ill Patients Terminated; Shares Plunge

Omeros Says Narsoplimab Arm of COVID-19 Treatment Trial in Critically Ill Patients Terminated; Shares Plunge

Omeros称新冠肺炎治疗危重患者的纳索普利单抗试验终止;股价暴跌
MT Newswires ·  2022/09/15 11:17

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发